GEA
HIMS icon

Glen Eagle Advisors’s Hims & Hers Health HIMS Stock Holding History

Glen Eagle Advisors’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25K Buy
36
+35
+3,500% +$940 ﹤0.01% 952
2026
Q1 		$21 Hold
1
– – ﹤0.01% 1015
2025
Q4 		$32 Buy
+1
New +$43 ﹤0.01% 1040
2021
Q4 		– Sell
-375
Closed -$2.83K – 1001
2021
Q3 		$2.83K Buy
+375
New +$3.18K ﹤0.01% 884

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Glen Eagle Advisors's HIMS Position: Q2 2026 in Review

Glen Eagle Advisors increased its Hims & Hers Health (HIMS) stake by 3,500% in Q2 2026, buying an estimated $940 and bringing the position to 36 shares worth $1.25K. The position accounts for ﹤0.01% of the portfolio, ranked #952.

Glen Eagle Advisors first reported a position in HIMS in Q3 2021 and has held it in 4 quarters since. The position peaked at $2.83K in Q3 2021. 507 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Glen Eagle Advisors held 36 shares of Hims & Hers Health worth $1.25K as of Q2 2026.
  • Glen Eagle Advisors bought 35 Hims & Hers Health shares in Q2 2026, an estimated $940.
  • Hims & Hers Health made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q2 2026, its #952 holding.
  • Glen Eagle Advisors first reported a position in Hims & Hers Health in Q3 2021 and has held it in 4 quarters since.
  • Glen Eagle Advisors's Hims & Hers Health position peaked at $2.83K in Q3 2021.
  • 507 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.